F13.22
Sedative, hypnotic or anxiolytic dependence with intoxication
Clinical Classification Guidelines
Excludes Type 1
- sedative, hypnotic or anxiolytic dependence with withdrawal (F13.23-)
Medical Intelligence & Overview
ICD-10 Code F13.22 refers to a condition where an individual develops dependence on sedative, hypnotic, or anxiolytic medications, accompanied by intoxication. These medications are often prescribed to treat anxiety, insomnia, or related conditions. Dependence indicates a physical or psychological need for the drug, while intoxication involves impaired mental or physical functioning due to the substance's effects. Recognizing this condition is crucial for managing health and preventing potential complications.
Causes & Symptoms
Clinical Causes: Chronic use of sedative, hypnotic, or anxiolytic medications beyond the prescribed duration or dosage. Use of these medications without medical supervision or for non-medical reasons. Underlying mental health conditions such as anxiety or insomnia that increase reliance on these drugs. History of substance use disorder, making an individual more susceptible to dependence.
Key Symptoms: Impaired judgment or coordination Memory problems or forgetfulness Slurred speech Dizziness or feeling lightheaded Reduced alertness or drowsiness Mood swings or irritability Dependence symptoms such as cravings or inability to stop using the medication Worsening of mental health issues when not taking the medication
Diagnostic & Treatment
Diagnosis Path: Diagnosis of F13.22 involves a comprehensive clinical assessment, including reviewing the patient's medical history, medication usage patterns, and signs of intoxication. Healthcare providers may use screening tools or structured interviews to evaluate the severity of dependence and intoxication. Laboratory tests, such as blood or urine analysis, can sometimes support the diagnosis by detecting the presence of the medication or its metabolites.
Treatment Protocols: Treating dependence with intoxication typically requires a multifaceted approach, tailored to the individual's needs. Common strategies include: - **Medication Management**: Gradual reduction or cessation of sedative, hypnotic, or anxiolytic medications under medical supervision. - **Supportive Care**: Monitoring for withdrawal symptoms and providing interventions to manage discomfort. - **Psychotherapy**: Cognitive-behavioral therapy (CBT) or counseling to address underlying issues related to anxiety, insomnia, or dependence. - **Hospitalization**: In cases of severe intoxication or dependence, inpatient care may be necessary. - **Long-term Follow-up**: Ongoing support and relapse prevention to maintain sobriety and manage mental health concerns. It is important to consult healthcare professionals for a personalized treatment plan and to ensure safe management of the condition.
Clinical Advice & FAQs
Billing Guidance
Is F13.22 a billable ICD-10 code?
Yes, F13.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.22?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with intoxication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference